Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 30;26(7):1217-1232.
doi: 10.1093/ehjci/jeaf124.

Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy

Affiliations

Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy

Giovanni Donato Aquaro et al. Eur Heart J Cardiovasc Imaging. .

Abstract

Aims: Arrhythmic risk stratification in patients with non-ischaemic dilated cardiomyopathy (DCM) remains challenging. The LGE-dispersion mapping is a novel method for the quantification of tissue heterogeneity through the Global Dispersion Score (GDS). We sought to evaluate the usefulness of GDS in arrhythmic risk stratification of DCM patients.

Methods and results: Consecutive non-ischaemic DCM patients underwent cardiac magnetic resonance imaging. GDS was calculated in LGE images. During a follow-up of 3.3 years (2 to 6 years), the combined endpoint of sudden cardiac death and appropriate implantable cardioverter-defibrillator intervention was considered. The final population included 510 patients (mean age was 56 ± 15 years). Left ventricular ejection fraction (LVEF) was >35% in 241 patients (47%). LGE was present in 225 patients (45%). Median extent of LGE was 12% of LV mass [interquartile range (IQR) 6-20%]. Among patients with positive LGE, GDS was 0.14 (IQR 0.08-0.20). During follow-up 81 patients had malignant ventricular arrhythmias (8 SCD, 73 appropriate ICD interventions). At Kaplan-Meier analysis, patients with GDS > 0.10 had worse prognosis than those with lower values of GDS (P < 0.0001). At multivariate analysis, GDS > 0.10 (HR 2.9, 95% CI: 1.7-5, P = 0.0002) was an independent predictor of events. The prognostic value of GDS was confirmed in subgroups of patients with LVEF ≤ 35% and >35%.

Conclusion: GDS is a useful marker to identify DCM patients at higher risk for malignant arrhythmic events regardless of LVEF and extent of LGE.

Keywords: cardiac magnetic resonance; dilated cardiomyopathy; late gadolinium enhancement; ventricular arrhythmias.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Similar articles

Cited by

  • Cardiovascular imaging in 2024: review of current research and innovations.
    Barison A, Timoteo AT, El Messaoudi S, Borodzicz-Jazdzyk S, Moscatelli S, Mandoli GE, Luong C, Levelt E, Ramkisoensing AA, Raisi-Estabragh Z, Antonopoulos A, Moharem-Elgamal S, Liga R, Pontone G, Neglia D. Barison A, et al. Eur Heart J Imaging Methods Pract. 2025 May 17;3(1):qyaf066. doi: 10.1093/ehjimp/qyaf066. eCollection 2025 Jan. Eur Heart J Imaging Methods Pract. 2025. PMID: 40469529 Free PMC article. Review.
  • Cardiac Magnetic Resonance Imaging and Arrhythmic Risk Stratification in Cardiomyopathies.
    Di Bella G, Micari A, Licordari R, Crea P, Colarusso L, Cusmà-Piccione M, Donato R, D'Angelo T, Dattilo G, Recupero A, de Gregorio C, Micari A, Donato Aquaro G. Di Bella G, et al. J Clin Med. 2025 Jul 11;14(14):4922. doi: 10.3390/jcm14144922. J Clin Med. 2025. PMID: 40725614 Free PMC article. Review.

MeSH terms